← Insider buys
BMRN

BioMarin Pharmaceutical Inc. · Healthcare

CEO Jean Jacques Bienaime sold $329K of BioMarin Pharmaceutical Inc.

Sold$328,625
$82.16Price
4,000Shares
−1%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Wed, May 8. Filed Thu, May 9, 8:32 PM ET, after the close. Not investment advice.